MyAverix Finance
F · Healthcare
AKANDA CORP. (Y23)
Drug Manufacturers - Specialty & Generic
AKANDA CORP. (Y23) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for Y23
AKANDA CORP. (Y23) — FAQ
What is Y23's P/E ratio?
The price-to-earnings (P/E) ratio for AKANDA CORP. (Y23) is 18.00 (data as of 2026-05-21).
Does AKANDA CORP. pay a dividend?
Dividend yield is not available in the current snapshot for AKANDA CORP. (Y23). Check the MyAverix Finance app for the latest dividend data.
What sector is AKANDA CORP. in?
AKANDA CORP. (Y23) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is Y23 listed on?
Y23 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.